Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Name: Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Published: 2025
License: Public Domain

RTOG Foundation, Inc. · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

intracranial meningioma, momentum-1, meningioma, advanced intracranial meningioma, sstr2, radiopharmaceuticals, theranostics, radioligand therapy, lu-dotatate, lutathera, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Related documents